Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.
Peter V. Adrian,Keith P. Klugman +1 more
TLDR
The resistant dihydrofolate reductases were characterized by highly conserved redundant changes in the nucleotide sequence, suggesting that the genes encoding resistant diHydrofolates reductase may have evolved as a result of inter- or intraspecies recombination by transformation.Abstract:
Streptococcus pneumoniae isolates resistant to several antimicrobial agent classes including trimethoprim-sulfamethoxazole have been reported with increasing frequency throughout the world. The MICs of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole (1:19) for 259 clinical isolates from South Africa were determined, and 166 of these 259 (64%) isolates were resistant to trimethoprim-sulfamethoxazole (MICs > or =20 mg/liter). Trimethoprim resistance was found to be more strongly correlated with trimethoprim-sulfamethoxazole resistance (correlation coefficient, 0.744) than was sulfamethoxazole resistance (correlation coefficient, 0.441). The dihydrofolate reductase genes from 11 trimethoprim-resistant (MICs, 64 to 512 microg/ml) clinical isolates of Streptococcus pneumoniae were amplified by PCR, and the nucleotide sequences were determined. Two main groups of mutations to the dihydrofolate reductase gene were found. Both groups shared six amino acid changes (Glu20-Asp, Pro70-Ser, Gln81-His, Asp92-Ala, Ile100-Leu, and Leu135-Phe). The first group included two extra changes (Lys60-Gln and Pro111-Ser), and the second group was characterized by six additional amino acid changes (Glu14-Asp, Ile74-Leu, Gln91-His, Glu94-Asp, Phe147-Ser, and Ala149-Thr). Chromosomal DNA from resistant isolates and cloned PCR products of the genes encoding resistant dihydrofolate reductases were capable of transforming a susceptible strain of S. pneumoniae to trimethoprim resistance. The inhibitor profiles of recombinant dihydrofolate reductase from resistant and susceptible isolates revealed that the dihydrofolate reductase from trimethoprim-resistant isolates was 50-fold more resistant (50% inhibitory doses [ID50s], 3.9 to 7.3 microM) than that from susceptible strains (ID50s, 0.15 microM). Site-directed mutagenesis experiments revealed that one mutation, Ile100-Leu, resulted in a 50-fold increase in the ID50 of trimethoprim. The resistant dihydrofolate reductases were characterized by highly conserved redundant changes in the nucleotide sequence, suggesting that the genes encoding resistant dihydrofolate reductases may have evolved as a result of inter- or intraspecies recombination by transformation.read more
Citations
More filters
Journal ArticleDOI
Antimicrobial resistance in developing countries.
TL;DR: Better access to diagnostic laboratories is needed, as well as improved surveillance of the emergence of resistance, better regulation of antibiotics' use, and better education of the public, physicians, and veterinarians in the appropriate use of drugs.
Journal ArticleDOI
Antimicrobial Resistance in Haemophilus influenzae
TL;DR: Haemophilus influenzae is a major community-acquired pathogen causing significant morbidity and mortality worldwide, and strains with alterations in penicillin binding proteins, particularly PBP3 (β-lactamase negative ampicillin resistant and β-l lactamase positive amoxicillin-clavulanate resistant), are increasing in prevalence.
Journal ArticleDOI
Dense genomic sampling identifies highways of pneumococcal recombination
Claire Chewapreecha,Simon R. Harris,Nicholas J. Croucher,Claudia Turner,Claudia Turner,Claudia Turner,Pekka Marttinen,Lu Cheng,Alberto Pessia,David M. Aanensen,Alison E. Mather,Andrew J. Page,Susannah J. Salter,David Harris,François Nosten,François Nosten,David Goldblatt,Jukka Corander,Jukka Corander,Jukka Corander,Julian Parkhill,Paul Turner,Paul Turner,Paul Turner,Stephen D. Bentley,Stephen D. Bentley +25 more
TL;DR: In this article, the authors report whole-genome sequencing of 3,085 pneumococcal carriage isolates from a 2.4km(2) refugee camp, which provides unprecedented resolution of the process of recombination and its impact on population evolution.
Journal ArticleDOI
Resistance to trimethoprim and sulfonamides
TL;DR: The trade-off, seen in laboratory experiments selecting resistance mutants, seems to be adjusted for by compensatory mutations in clinically isolated drug-resistant pathogens, which means that susceptibility will not return after suspending the use of sulfonamide and trimethoprim.
Journal ArticleDOI
Dihydrofolate reductase inhibitors as antibacterial agents
TL;DR: The success in exploiting DHFR as a drugable target as exemplified by trimethoprim (TMP) and the development of several new diaminopyrimidines is described and several examples of anti-DHFR antibacterial compounds in pre-clinical development are described.
References
More filters
Journal ArticleDOI
DNA sequencing with chain-terminating inhibitors
TL;DR: A new method for determining nucleotide sequences in DNA is described, which makes use of the 2',3'-dideoxy and arabinon nucleoside analogues of the normal deoxynucleoside triphosphates, which act as specific chain-terminating inhibitors of DNA polymerase.
Journal ArticleDOI
National Committee for Clinical Laboratory Standards.
TL;DR: Many members of the Academy of Pediatrics seem to be generally unaware of the fact that the Academy has participated for ten years in a very interesting and valuable organization, the National Committee for Clinical Laboratory Standards (NCCLS).
Journal ArticleDOI
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
Fred C. Tenover,Robert D. Arbeit,Richard V. Goering,P. A. Mickelsen,Barbara E Murray,D. H. Persing,B. Swaminathan +6 more
TL;DR: This research presents a novel, scalable and scalable approach that allows for real-time assessment of the severity of the infection and its impact on patients’ health.
Journal ArticleDOI
High efficiency transformation of E.coli by high voltage electroporation
TL;DR: E. coli can be transformed to extremely high efficiencies by subjecting a mixture of cells and DNA to brief but intense electrical fields of exponential decay waveform (electroporation), and most of the surviving cells are competent with up to 80% transformed at high DNA concentration.